SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Fluxion Biosciences, Inc. announced today that it has initiated a collaboration with the Stanford University School of Medicine focused on developing tests to help deliver more effective therapies to cancer patients. The laboratory of Dr. James Brooks is utilizing Fluxion’s IsoFlux System to isolate, recover, and analyze rare circulating cancer cells at the molecular level.
Help employers find you! Check out all the jobs and post your resume.
